A Decentralized Clinical Trial (DCT) is a study model that leverages technology and remote processes to conduct research outside traditional clinical settings. DCTs allow participants to engage in trials from their homes or local healthcare facilities, reducing the need for frequent visits to centralized study sites.
This approach utilizes digital health technologies, telemedicine, and home health care services to collect data and monitor participants. DCTs aim to improve patient recruitment and retention by offering greater convenience and accessibility, particularly for individuals with mobility issues or those living in remote areas.
Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by addressing key challenges in traditional trial methodologies. They offer potential solutions to issues such as slow patient recruitment, high dropout rates, and limited diversity in study populations, which have long hindered the efficiency and representativeness of clinical studies.
The importance of DCTs has been further highlighted by global events like the COVID-19 pandemic, which necessitated alternative approaches to conducting research. By embracing DCTs, the clinical research industry can enhance patient-centricity, improve data quality through continuous monitoring, and potentially accelerate the drug development process, leading to faster delivery of new treatments to patients.
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
How Axcellant stabilized isotope supply, synchronized global imaging operations, and prevented a multi-month program delay. At a Glance Study type:…
At Axcellant, we work where medtech becomes real, not in headlines but in clinics, documentation, and decisions that must stand…
Copyright @ 2026 Axcellant